Physician profile
James E Martinez
NPI 1649279944
$2,216.29
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,776 · 2020: $298 · 2021: $57.56 · 2022: $57.44 · 2023: $27.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $858.98 | 2019 | |
| Abbvie INC. | $491.96 | 2019-2023 | |
| Gilead Sciences, INC. | $186.45 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $181.86 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.56 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.84 | 2019-2022 | |
| Janssen Biotech, INC. | $66.69 | 2019-2020 | |
| Daiichi Sankyo INC. | $61.03 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $36.52 | 2019 | |
| Allergan, INC. | $28.48 | 2019 | |
| Shire North American Group INC | $27.54 | 2019 | |
| Aries Pharmaceuticals, INC. | $23.96 | 2019 | |
| Pfizer INC. | $14.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.